Cargando…
Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and mana...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153846/ https://www.ncbi.nlm.nih.gov/pubmed/34041585 http://dx.doi.org/10.1007/s00604-021-04867-1 |
_version_ | 1783698885789614080 |
---|---|
author | Eissa, Shimaa Alhadrami, Hani A. Al-Mozaini, Maha Hassan, Ahmed M. Zourob, Mohammed |
author_facet | Eissa, Shimaa Alhadrami, Hani A. Al-Mozaini, Maha Hassan, Ahmed M. Zourob, Mohammed |
author_sort | Eissa, Shimaa |
collection | PubMed |
description | Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL(−1) to 100 ng.mL(−1) and a limit of detection of 0.4 pg.mL(−1) for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection. |
format | Online Article Text |
id | pubmed-8153846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-81538462021-05-28 Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen Eissa, Shimaa Alhadrami, Hani A. Al-Mozaini, Maha Hassan, Ahmed M. Zourob, Mohammed Mikrochim Acta Original Paper Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL(−1) to 100 ng.mL(−1) and a limit of detection of 0.4 pg.mL(−1) for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection. Springer Vienna 2021-05-26 2021 /pmc/articles/PMC8153846/ /pubmed/34041585 http://dx.doi.org/10.1007/s00604-021-04867-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Eissa, Shimaa Alhadrami, Hani A. Al-Mozaini, Maha Hassan, Ahmed M. Zourob, Mohammed Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title | Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title_full | Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title_fullStr | Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title_full_unstemmed | Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title_short | Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen |
title_sort | voltammetric-based immunosensor for the detection of sars-cov-2 nucleocapsid antigen |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153846/ https://www.ncbi.nlm.nih.gov/pubmed/34041585 http://dx.doi.org/10.1007/s00604-021-04867-1 |
work_keys_str_mv | AT eissashimaa voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen AT alhadramihania voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen AT almozainimaha voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen AT hassanahmedm voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen AT zourobmohammed voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen |